Abstract
Bipolar disorder (BD) is characterized by a dynamic process encompassing various episode states, including manic episodes (BipM), depressive episodes (BipD), and periods of remission (rBD). Various cognitive and behavioral alterations induced by extreme emotions are implicated across different episodes. However, how exactly brain function is reorganized during these episodes remains largely unstudied. Here, we used low-dimensional representations of brain functions to study the functional organization in individuals with BipM, BipD, rBD, and healthy controls (HC). We found that similar sensory-association reorganization principle across all three episodes, compared to healthy controls. In particular, expansion in sensory regions and compression in association regions were the key principles for reorganization of low-dimensional representation of brain function in BD. Furthermore, such large-scale hierarchical functional reorganization was associated with clinical symptoms at different episodes. Next, this study also implemented regional outward and inward activity propagation to study the information flow in the altered regions. It revealed that all the three episodes had less frequent flows in association regions, clarifying association may be dominant in functional reorganization. By applying a network integration-segregation model, we also observed an increase in functional integration alongside a decrease in functional segregation. Finally, various receptors that were spatially correlated with the episode t-maps including serotonin transporter, gamma-aminobutyric acid type A receptor, Alpha-4-Beta-4 nicotinic acetylcholine receptor, and cell profiles including Layer 4 and Layer 5 thick-tufted cells. This study demonstrates that association-dominated binary functional hierarchical anchors could systematically elucidate abnormal neural phenotypes across various BD states.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted following ethical approval from the Ethics Committee of Renmin Hospital of Wuhan University (Ethics Approval Number: WDRY22022-K195).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
